| Biosimilar Study Comparing PK, PD, Safety and Immunogencity of BP11 With US Licensed Xolair and EU Approved Xolair (NCT05053334) | Syneos Health | 2022-02-16 |
| Tolerability and Safety of HF1K16 Injection in Patients With Refractory Solid Tumors (NCT05388487) | HighField Biopharmaceuticals Corporation | 2022-02-16 |
| Targeted Elimination Diet in EoE Patients Following Identification of Trigger Nutrients Using Confocal Laser Endomicroscopy (NCT05695456) | Universitaire Ziekenhuizen KU Leuven | 2022-02-16 |
| Safety and Immunogenicity Study of COVID-19 Protein Subunit Recombinant Vaccine Adjuvanted With Alum+CpG 1018 (NCT05228613) | PT Bio Farma | 2022-02-16 |
| Optimized Dual CD33/CLL1 CAR T Cells in Subjects With Refractory or Relapsed Acute Myeloid Leukemia (NCT05248685) | Beijing Boren Hospital | 2022-02-16 |
| Nicotine Differences in Smokers (NCT05159934) | Yale University | 2022-02-16 |
| A Study to Evaluate the Safety and Efficacy of ZS801 in Adult Hemophilia B Patients (NCT05641610) | Institute of Hematology & Blood Diseases Hospital, China | 2022-02-16 |
| Evaluation of Two Zika Viruses for Use in Controlled Human Infection Models (CHIM) (NCT05123222) | National Institute of Allergy and Infectious Diseases (NIAID) | 2022-02-16 |
| Alectinib in Combination With Nivolumab in the Treatment of Recurrent or Refractory HCC Patients Guided With Serum RNase1 and Tumor Expression of PD-L1 (NCT06354387) | China Medical University Hospital | 2022-02-16 |
| P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors (NCT05239143) | Poseida Therapeutics, Inc. | 2022-02-15 |
| A Study to Evaluate the Ability of UB-612 COVID-19 Vaccine to Boost Immunity of Heterologous COVID-19 Vaccines. (NCT05167253) | United Biomedical Inc., Asia | 2022-02-15 |
| Safety and Efficacy of CKDB-501A in Subjects With Moderate-to-severe Glabellar Lines (NCT05292638) | CKD Bio Corporation | 2022-02-15 |
| 18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant (NCT02379377) | M.D. Anderson Cancer Center | 2022-02-15 |
| A Gene Therapy Study of BMN 331 in Subjects With Hereditary Angioedema (NCT05121376) | BioMarin Pharmaceutical | 2022-02-15 |
| IMM2902 in Patients With Advanced Solid Tumors Expressing HER2 (NCT05805956) | ImmuneOnco Biopharmaceuticals (Shanghai) Inc. | 2022-02-15 |
| Blood-Stage Plasmodium Vivax Cell Bank (NCT05095272) | National Institute of Allergy and Infectious Diseases (NIAID) | 2022-02-15 |
| Clinical Study of Hospital-manufactured CD19 CAR-T in Children and Adolescents With Acute Lymphoblastic Leukemia (NCT05210907) | Seoul National University Hospital | 2022-02-15 |
| Coconut Oil in Treatment of Periodontitis (NCT06384638) | Misr University for Science and Technology | 2022-02-15 |
| Anakinra for Preterm Infants Pilot (NCT05280340) | Monash Medical Centre | 2022-02-15 |
| HMPL-760 Safety and Tolerability Study in Patients With Previously Treated CLL/SLL or NHL (NCT05176691) | Hutchmed | 2022-02-15 |
| The Effects of NSAIDs on Bone Metabolism Following Exercise (NCT05512013) | United States Army Research Institute of Environmental Medicine | 2022-02-15 |
| Berzosertib Human Mass Balance Study (DDRiver Solid Tumors 208) (NCT05246111) | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | 2022-02-15 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of KUR-101 in Healthy Adults (NCT05114265) | Kures, Inc. | 2022-02-15 |
| To Evaluate the Safety and Pharmacokinetic Characteristics After the Administration of JC-001 and JLP-1901 (NCT06171880) | Jeil Pharmaceutical Co., Ltd. | 2022-02-15 |
| A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Urological Tumors and Other Solid Tumors (NCT05393427) | Sichuan Baili Pharmaceutical Co., Ltd. | 2022-02-15 |
| Study to Assess the Pharmacokinetics of CT1812 in Older Healthy Volunteers (NCT05248672) | Cognition Therapeutics | 2022-02-15 |
| Automated Robotic Maneuvering System (RMS) vs Manual Reposition Maneuver in Treatment of Benign Paroxysmal Positional Vertigo (BPPV) (NCT05352555) | Stratejik Yenilikci Girisimler Ltd. | 2022-02-15 |
| Cefazolin PK Study 3g vs 2g (NCT05309304) | Baxter Healthcare Corporation | 2022-02-14 |
| A Study of LY900014 (Lyumjev) Versus Insulin Lispro (Humalog) in Participants With Type 1 Diabetes (NCT05262387) | Eli Lilly and Company | 2022-02-14 |
| Study of MGTA-117 in Patients With Adult Acute Myeloid Leukemia (AML) and Myelodysplasia-Excess Blasts (MDS-EB) (NCT05223699) | Magenta Therapeutics, Inc. | 2022-02-14 |
| Sustained Acoustic Medicine for Osteoarthritis Pain (NCT05254574) | ZetrOZ, Inc. | 2022-02-14 |
| Safety and Efficacy of Expanded, Universal Donor Natural Killer Cells for Relapsed/Refractory AML (NCT05503134) | Nationwide Children's Hospital | 2022-02-14 |
| Safety, Tolerability, Pharmacokinetics and Target Engagement of GSK3858279 in Healthy Caucasian, Chinese and Japanese Participants (NCT05174013) | GlaxoSmithKline | 2022-02-14 |
| Bioavailability of Levodopa 250 mg and Carbidopa 25 mg With Regards to Reference Product (NCT05250141) | Laboratorios Andromaco S.A. | 2022-02-14 |
| A Study of PRT2527 in Participants With Advanced Solid Tumors (NCT05159518) | Prelude Therapeutics | 2022-02-14 |
| A Healthy Volunteer Safety Study of Pyronaridine Tetraphosphate Taken in Combination With Piperaquine Tetraphosphate (NCT05160363) | Medicines for Malaria Venture | 2022-02-14 |
| Single Ascending Dose Study With BPL-003 in Healthy Subjects (NCT05347849) | Beckley Psytech Limited | 2022-02-14 |
| First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies (NCT05627960) | A&G Pharmaceutical Inc. | 2022-02-14 |
| Pilot Trial of Colchicine in Urothelial Cancer and Other Solid Tumors (NCT05279690) | Icahn School of Medicine at Mount Sinai | 2022-02-14 |
| Study to Evaluate the Safety and PK Properties of DWP16001 in Healthy Subjects With Various Ethnicities (NCT05207176) | Daewoong Pharmaceutical Co. LTD. | 2022-02-14 |
| UP-818-CC Injection in Healthy Chinese Subjects (NCT07355621) | EnliTISA (Shanghai) Pharmaceutical Co., Ltd. | 2022-02-14 |
| A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumor and Other Solid Tumor (NCT05262491) | Sichuan Baili Pharmaceutical Co., Ltd. | 2022-02-14 |
| Bioequivalence Study Between Capoten Versus Captopril Reference Product in Healthy Adult Participants Under Fasting Conditions (NCT04878315) | GlaxoSmithKline | 2022-02-13 |
| Crossover Study to Evaluate the Effect of Food on the Pharmacokinetics of SLC-391 in Healthy Adult Subjects (NCT05278845) | SignalChem Lifesciences Corporation | 2022-02-12 |
| A Study of NOX66 Plus Doxorubicin in Anthracycline-naïve, Adult Patients With Soft Tissue Sarcoma (NCT05100628) | Noxopharm Limited | 2022-02-11 |
| Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01) (NCT05259696) | Palleon Pharmaceuticals, Inc. | 2022-02-11 |
| A Clinical Trial to Evaluate the Safety and Immunogenicity of BG505 MD39.3, BG505 MD39.3 gp151, and BG505 MD39.3 gp151 CD4KO HIV Trimer mRNA Vaccines in Healthy, HIV-uninfected Adult Participants (NCT05217641) | National Institute of Allergy and Infectious Diseases (NIAID) | 2022-02-11 |
| Effect of Acetaminophen and N-Acetylcysteine on Liver Metabolism on Homocystinuria (NCT04015557) | Hospital de Clinicas de Porto Alegre | 2022-02-11 |
| Safety and Immunogenicity of Prime-boost Vaccination of SARS-CoV-2 in Patients With Cancer (NCT05273541) | Beijing 302 Hospital | 2022-02-11 |
| Phase I Study of Repotrectinib and Osimertinib in NSCLC Patients (NCT04772235) | Instituto Oncológico Dr Rosell | 2022-02-11 |
| CC-42344 Safety Study in Healthy Participants (NCT05202379) | Cocrystal Pharma, Inc. | 2022-02-11 |
| Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors (NCT05269316) | Impact Therapeutics, Inc. | 2022-02-11 |
| Pharmacokinetic Comparability Study in Healthy Participants - PF-06881894 On-Body Injector Relative to Prefilled Syringe (NCT05194579) | Pfizer | 2022-02-10 |
| A Study to Evaluate Pharmacokinetics (PK) of Etrumadenant Tablet and Capsule Formulations in Healthy Adult Participants (NCT05277012) | Arcus Biosciences, Inc. | 2022-02-10 |
| A Phase I Study to Assess the Pharmacokinetics of Olorofim in Subjects With Renal Impairment (NCT05200286) | F2G Biotech GmbH | 2022-02-10 |
| Study of the Effect of Food Intake on the Bioavailability of XC221 100 mg Tablets (NCT05295121) | Valenta Pharm JSC | 2022-02-10 |
| Testing Oral Decitabine and Cedazuridine (ASTX727) in Combination With Venetoclax for Higher-Risk Acute Myeloid Leukemia Patients (NCT04817241) | National Cancer Institute (NCI) | 2022-02-10 |
| A Clinical Study of the Safety and Tolerability of SHR-1901 in Subjects With Advanced Malignant Tumors (NCT05193721) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2022-02-10 |
| Intralymphatic Immunotherapy With Polvac Grass & Rye Allergen Extract (NCT05297760) | University of Zurich | 2022-02-10 |
| Study in Subjects to Evaluate the Safety, Tolerability and Pharmacokinetics of GT20029 (NCT05428449) | Suzhou Kintor Pharmaceutical Inc, | 2022-02-10 |
| Study Of B7H3 CAR-T Cells in Treating Advanced Liver Cancer (NCT05323201) | The Affiliated Hospital of Xuzhou Medical University | 2022-02-10 |
| A Study Explore JS001+JS002 in Patients With Advanced Cancer (NCT05128539) | Shanghai Junshi Bioscience Co., Ltd. | 2022-02-10 |
| Evaluating the Safety, Tolerability, and Pharmacokinetics of BAT1006 (NCT05414136) | Bio-Thera Solutions | 2022-02-10 |
| To Evaluate the Safety and Tolerability of Human CD19-CD22 Targeted T Cells Injection for Subjects With R/R B-ALL. (NCT05223686) | Hrain Biotechnology Co., Ltd. | 2022-02-10 |
| Safety and Tolerability of CFTX-1554 in Healthy Subjects (NCT05260658) | Confo Therapeutics | 2022-02-09 |
| ADG116 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors (NCT05277402) | Adagene Inc | 2022-02-09 |
| A First in Human Study of the Safety, Tolerability and Pharmacokinetics of PRV-002 in Healthy Volunteers (NCT05033444) | Odyssey Group International, Inc. | 2022-02-09 |
| Cabozantinib and Pamiparib for the Treatment of Advanced of Refractory Solid Tumors (NCT05038839) | M.D. Anderson Cancer Center | 2022-02-09 |
| A Study of GNC-035, a Tetra-specific Antibody, in Participants With Relapsed/Refractory Hematologic Malignancy (NCT05104775) | Sichuan Baili Pharmaceutical Co., Ltd. | 2022-02-09 |
| Evaluation of Endoscopic Surgical Field Clarity Using Hot Saline Versus Lactated Ringer's Irrigation (NCT05161780) | Carl Snyderman | 2022-02-09 |
| A Safety Study of Lactobacillus Reuteri BGP-014 in Patients With Ulcerative Colitis (NCT05118919) | BioGaia Pharma AB | 2022-02-09 |
| A First-in-human Study of Multiple Doses of Topically Administered PF-07295324 and PF-07259955 (NCT05206604) | Pfizer | 2022-02-09 |
| A Live Recombinant Newcastle Disease Virus-vectored COVID-19 Vaccine Phase 1 Study. (NCT05181709) | Sean Liu | 2022-02-09 |
| A Phase I Study of IBI325 in Patients With Advanced Solid Tumor (NCT05119998) | Innovent Biologics (Suzhou) Co. Ltd. | 2022-02-08 |
| A Safety and Activity Study of SBT6050 in Combination With Other HER2-directed Therapies for HER2-positive Cancers (NCT05091528) | Silverback Therapeutics | 2022-02-08 |
| Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer (NCT05106296) | Theodore S. Johnson | 2022-02-08 |
| In Vivo Study of THC-induced Immune-genome Changes at Single Cell Solution in HIV-infected Humans (NCT04920539) | Yale University | 2022-02-08 |
| Exploratory Study of a Novel Oncolytic Vaccinia Virus RGV004 in the Treatment of Refractory/Relapsed B-cell Lymphoma (NCT04887025) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2022-02-08 |
| A Research Study Looking at How 50 mg Semaglutide Daily Affects Food Intake and Emptying of the Stomach in People With Obesity (NCT05236517) | Novo Nordisk A/S | 2022-02-08 |
| Study of ONO-7914 Alone and in Combination With ONO-4538 in Patients With Solid Tumors (NCT06535009) | Ono Pharmaceutical Co., Ltd. | 2022-02-08 |
| Safety and Preliminary Efficacy of BNA035 in Patients With Advanced Solid Tumors (NCT05150457) | Binacea Pharma, Inc. | 2022-02-08 |
| Hotspot TCR-T: A Phase I/Ib Study of Adoptively Transferred T-cell Receptor Gene-engineered T Cells (TCR-T) (NCT04520711) | Providence Health & Services | 2022-02-08 |
| UNAIR Inactivated COVID-19 Vaccine (NCT05226429) | Dr. Soetomo General Hospital | 2022-02-08 |
| A Study in Healthy Japanese and Chinese Men to Test How Well Different Doses of BI 706321 Are Tolerated (NCT05183360) | Boehringer Ingelheim | 2022-02-07 |
| A Clinical Trial of AAV2-BDNF Gene Therapy in Early Alzheimer's Disease and Mild Cognitive Impairment (NCT05040217) | Mark Tuszynski | 2022-02-07 |
| Clinical Trial of Probiotic Supplementation in Psoriasis Vulgaris (NCT05254249) | Dr. Soetomo General Hospital | 2022-02-07 |
| The Study of Omalizumab (CMAB007 and Xolair) in Healthy Subjects to Compare the PK, PD, Safety and Immunogenicity (NCT05897008) | Taizhou Mabtech Pharmaceutical Co.,Ltd | 2022-02-07 |
| Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma (NCT04879043) | Heidelberg Pharma AG | 2022-02-07 |
| The Effect of Dicloxacillin on Oral Absorption of Drugs (NCT05073627) | University of Southern Denmark | 2022-02-07 |
| A Randomized Phase 1 of of MZE001 in Healthy Volunteers (NCT05249621) | Maze Therapeutics | 2022-02-07 |
| Umbilical Cord Blood Derived MAK Immune Cells Combined With Standard Second-Line Treatments for Hepatobiliary and Pancreatic Malignancies (NCT05240690) | Zhou Fuxiang | 2022-02-07 |
| Placebo-controlled, Single and Multiple Dose Study in Healthy Volunteers and Refractory Chronic Cough Patients to Assess the Safety, Tolerability, and Pharmacokinetics of Two Formulations of NTX-1175 (NCT05628740) | Nocion Therapeutics | 2022-02-07 |
| A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVSQIV in Healthy Adults (NCT05252338) | CureVac | 2022-02-07 |
| Safety and Immunogenicity Study of EgyVax Vaccine Candidate for Prophylaxis of COVID-19 Infection (NCT05218070) | Eva Pharma | 2022-02-06 |
| Lurbinectedin + Doxorubicin In Leiomyosarcoma (NCT05099666) | Massachusetts General Hospital | 2022-02-04 |
| A Study of LY3871801 in Healthy Participants (NCT05222399) | Eli Lilly and Company | 2022-02-04 |
| Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms (NCT04797767) | University of Washington | 2022-02-04 |
| Effectiveness of Preurodynamic With Posturodynamic Levofloxacin on the Incidence of UTI (NCT05219877) | Indonesia University | 2022-02-04 |
| A Study of Fixed Dose Combination of Macitentan/Tadalafil (10 mg/20 mg) Compared to the Reference Free Combination of Macitentan and Tadalafil in Healthy Adult Participants (NCT05236231) | Actelion | 2022-02-04 |
| A Study in Healthy Japanese Men to Test How Well Different Doses of BI 1291583 Are Tolerated (NCT05183347) | Boehringer Ingelheim | 2022-02-04 |